The Effects of Bisphosphonates Used in Osteoporosis Treatment on Breast Cancer: Analysis with Integrative Bioinformatics Methods, DFT, ADMET and Molecular Docking Analysis. [PDF]
Dogan SC, Goren K.
europepmc +1 more source
Efficacy of once-weekly teriparatide versus alendronate in Chinese postmenopausal osteoporosis: a randomised, open-label, active-controlled, 48-week, multicentre phase III study. [PDF]
Gu J +41 more
europepmc +1 more source
Cardiovascular Safety Signals of Osteoporosis Therapies: A FAERS Pharmacovigilance Study. [PDF]
Sondhi M, Singh N, Carkin J, Hughes G.
europepmc +1 more source
Age-dependent musculoskeletal changes during mechanical unloading with bisphosphonate treatment. [PDF]
Orr SV +6 more
europepmc +1 more source
Expected change: a new concept for monitoring patients on oral bisphosphonates. [PDF]
Schini M +4 more
europepmc +1 more source
From Risk to Treatment: Clinical Updates in Osteoporosis Management. [PDF]
Alchi K, Chan A.
europepmc +1 more source
Perioperative denosumab exposure and risk of revision after total hip and knee arthroplasty in osteoarthritis: a registry-based data linkage study. [PDF]
Ciaffi J +9 more
europepmc +1 more source
Longitudinal osteoporosis therapy: treat-to-target and sequential strategies-a narrative review. [PDF]
Tskhakaia I, Danila MI.
europepmc +1 more source
Efficacy and safety of denosumab, zoledronic acid and alendronate on bone mineral density and trabecular bone score in men with osteoporosis. [PDF]
Zhou B +11 more
europepmc +1 more source
From efficacy to effectiveness: additional considerations on once-weekly teriparatide for postmenopausal osteoporosis. [PDF]
Chen C, Zhang J, Huang T.
europepmc +1 more source

